Friend,

David Perdue has used his position of public trust to enrich himself from the very first days after he was elected to the Senate, according to a new report published yesterday by The Intercept.

In 2014, he secured stock options from the financial technology company Cardlytics where he served as a board member, options that “would grow to be worth more than $6 million” as Perdue “has worked to roll back regulations that govern firms like Cardlytics...and has sponsored legislation that would be to the firm’s benefit.”

Already this year, Perdue’s stock trades following a secret Senate briefing on coronavirus have raised ethical red flags, with possible evidence of insider trading. Now we are learning the details of how he has legislatively engineered the conditions under which his own investment is able to grow. It bewilders me that such an action is not itself a crime — but it is without question unethical.

Here is the bottom line: David Perdue is not fit to serve. His self-interest and self-regard as Donald Trump’s man in the Senate have led us to a public health and economic crisis.

Polling shows our race is extremely competitive and Georgia is the battleground state in an expanded Senate map against vulnerable Republican incumbents.

We can win this race, but I need you to chip in right now with less than 4 weeks left before the June 9 primary election and help me take him on. Make your first donation right now at the most critical time for our campaign to take back the Senate majority.

If you've stored your info with ActBlue, we'll process your contribution instantly:

Thank you for your commitment and continued support.

Yours truly,
Teresa